Eclipse Bio’s miR-eCLIP™ service was cited in a recent publication, enabling the discovery of Tobramycin as a suppressing factor in lung inflammation, and as a gene silencing mechanism reducing IL-8 secretion in CF-HBECSs.
Find the publication here.